Cochrane Abstracts
Pharmacotherapy augmentation strategies in treatment‐resistant anxiety disorders
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Pharmacotherapy Augmentation Strategies in Treatment‐resistant Anxiety Disorders." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435988/all/Pharmacotherapy_augmentation_strategies_in_treatment‐resistant_anxiety_disorders.
Pharmacotherapy augmentation strategies in treatment‐resistant anxiety disorders. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435988/all/Pharmacotherapy_augmentation_strategies_in_treatment‐resistant_anxiety_disorders. Accessed December 8, 2024.
Pharmacotherapy augmentation strategies in treatment‐resistant anxiety disorders. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435988/all/Pharmacotherapy_augmentation_strategies_in_treatment‐resistant_anxiety_disorders
Pharmacotherapy Augmentation Strategies in Treatment‐resistant Anxiety Disorders [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435988/all/Pharmacotherapy_augmentation_strategies_in_treatment‐resistant_anxiety_disorders.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Pharmacotherapy augmentation strategies in treatment‐resistant anxiety disorders
ID - 435988
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435988/all/Pharmacotherapy_augmentation_strategies_in_treatment‐resistant_anxiety_disorders
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
